13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001351351
Total reported value
$223.5M
$223.5M
12 檔
68.2%
During the Q2 2025 filing period, Twin Securities, Inc. (CIK: 0001351351) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $223.5M across 12 reported positions.
Twin Securities, Inc. executed strategic sector rebalancing during Q2 2025, establishing 5 new positions while fully exiting 6 holdings and trimming 3 positions.
In terms of portfolio concentration, the top 5 core holdings (including BA, KEL, HES) accounted for 68.2% of total reported equity market value during Q2 2025.
Top New Position Initiated
BA
市值: $63.2M
Top Position Liquidated / Trimmed
ITCIEUR
前期市值: $58.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BA | Boeing Co/the | Stock-Industrials | 35.87% | — | — | |
| 2 | KEL | Kellanova | Stock-Other | 19.34% | — | +21.02% | |
| 3 | HES | Hess CORP | Stock-Other | 16.05% | — | +64.17% | |
| 4 | 2655787D | Blueprint Medicines CORP | Stock-Other | 8.74% | — | — | |
| 5 | SGRY | Surgery Partners Inc | Stock-Other | 6.45% | -0.06% | EXIT | |
| 6 | S9Q | Spirit Aerosystems Hold-cl A | Stock-Other | 5.49% | — | -14.70% | |
| 7 | TIC | Tic Solutions Inc | Stock-Other | 2.72% | +0.03% | +7.10% | |
| 8 | SWTXUSD | Springworks Therapeutics Inc | Stock-Other | 2.70% | — | -62.78% | |
| 9 | DNB | Dun & Bradstreet Holdings In | Stock-Other | 1.19% | — | — | |
| 10 | PZZA | Papa John's Intl Inc | Stock-Other | 0.98% | — | — | |
| 11 | WOO | Foot Locker Inc | Stock-Other | 0.35% | — | — | |
| 12 | MANU | Manchester United plc | Stock-Other | 0.12% | -0.12% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BA | Boeing Co/the | +35.9% | NEW | New buy |
| 2 | 2655787D | Blueprint Medicines CORP | +8.7% | NEW | New buy |
| 3 | HES | Hess CORP | +5.8% | +64.17% | Add |
| 4 | KEL | Kellanova | +4.3% | +21.02% | Add |
| 5 | SGRY | Surgery Partners Inc | +2.4% | +54.94% | Add |
| 6 | DNB | Dun & Bradstreet Holdings In | +1.2% | NEW | New buy |
| 7 | PZZA | Papa John's Intl Inc | +1% | NEW | New buy |
| 8 | TIC | Tic Solutions Inc | +0.4% | +7.10% | Add |
| 9 | WOO | Foot Locker Inc | +0.4% | NEW | New buy |
| 10 | S9Q | Spirit Aerosystems Hold-cl A | +0.2% | -14.70% | Trim |
| 11 | MANU | Manchester United plc | -0.1% | -67.31% | Trim |
| 12 | JNP | Juniper Networks Inc | -0.6% | EXIT | Sold out |
| 13 | CMRXEUR | Chimerix Inc | -0.9% | EXIT | Sold out |
| 14 | SWTXUSD | Springworks Therapeutics Inc | -3.5% | -62.78% | Trim |
| 15 | HEESEUR | H&e Equipment Services Inc | -5.4% | EXIT | Sold out |
| 16 | DFSEUR | Discover Financial Services | -5.8% | EXIT | Sold out |
| 17 | BECNUSD | Beacon Roofing Supply Inc | -13.8% | EXIT | Sold out |
| 18 | ITCIEUR | Intra-cellular Therapies Inc | -30% | EXIT | Sold out |
According to official SEC Form 13F filings, Twin Securities, Inc. reported a total U.S. public equity portfolio value of $223.5M across 12 disclosed positions in Q2 2025.
During Q2 2025, Twin Securities, Inc.'s top holdings by market value included BA (35.9%)、KEL (19.3%)、HES (16.1%). The largest single position, BA, represented 35.9% of total portfolio value.
In Q2 2025, Twin Securities, Inc. made 18 total portfolio adjustments, initiating 5 new buys, adding to 4 positions, trimming 3 holdings, and fully liquidating 6 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.